Author groups

About "Pharmaceuticals & life science"

The PwC pharmaceuticals and life science practice provides professional services to leading pharmaceuticals and life science organizations.

More about this author

Article archive

  • MoneyTree™ Life Sciences Report: Quarterly Q2 2015

    8/26/15 | Pharmaceuticals & life science

    US venture capital funding for the life sciences sector, which includes biotechnology and medical devices, increased 21% by value, but declined 2% by volume, on a year-over-year basis during the second quarter of 2015. Venture capitalists invested $3.1 billion in 201 life sciences deals in the second quarter of 2015, compared with $2.6 billion in 205 deals during the same quarter of 2014. Also, significant to note, Biotech investment was the highest since the start of the MoneyTree data series in 1995.

  • Rx Marketplace Quarterly, Issue 6

    6/25/15 | Pharmaceuticals & life science

    The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry.

  • MoneyTree™ Life Sciences Report: Quarterly Q1 2015

    6/8/15 | Pharmaceuticals & life science

    US capital funding for the Life Sciences sector, which includes biotechnology and medical devices, increased 34% in value and 4% in volume during the first quarter of 2015. Venture capitalists invested $2.2 billion in 193 life sciences deals in first quarter 2015, compared with $1.6 billion in 186 deals during the same quarter of 2014. Also, significant to note, Biotech investment during the quarter was the strongest first quarter for biotech since the start of the MoneyTree data series in 1995.

  • Rx Marketplace Quarterly, Issue 5

    3/24/15 | Pharmaceuticals & life science

    The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry.

  • Rx Marketplace Quarterly, Issue 4

    12/24/14 | Pharmaceuticals & life science

    The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry.

  • Research and Development (R&D) Funding Arrangements

    11/18/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Alert focuses on Research and Development (R&D) Funding Arrangements.

  • Change in timing for recording the Annual Pharmaceutical Fee

    10/15/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Alert focuses on the change in timing for the Annual Pharmaceutical Fee.

  • Rx Marketplace Quarterly, Issue 3

    10/2/14 | Pharmaceuticals & life science

    The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry.

  • Webcast
    Revenue Recognition Webcast & Industry Supplement - Pharmaceutical and Life Sciences Companies

    6/11/14 | Pharmaceuticals & life science

    Join us for an expanded discussion on the specific impacts the new revenue recognition standard will have on the Pharmaceutical and Life Sciences industry and download our P&LS Industry Supplement.

  • IPR&D acquired in a business combination – How many pieces?

    5/21/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Alert focuses on in-process research and development (IPR&D) in acquisition accounting.

  • Potential impacts to Pharma and Life Sciences companies of the new accounting definition of an "investment company"

    4/10/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Alert focuses on the key accounting considerations when assessing whether an entity is an investment company under the new accounting definition and provides illustrative examples.

  • Rx Marketplace Quarterly Newsletter

    3/27/14 | Pharmaceuticals & life science

    The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry. Each quarterly also shares strategies that companies can use to unlock divestiture value, as well as links to publications and online resources. In the spotlight in this issue is our summary of the IPO market, which has seen its most robust year since 2007. We cover key metrics for the past year, assess the industry’s top registrants, and offer a snapshot of IPO activity during the first two months of 2014.

  • Distinguishing a Business from an Asset or a Group of Assets

    1/16/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Industry GAAP Alert focuses on the key accounting considerations when making this determination and provides illustrative examples.

  • US GAAP: Issues and solutions for pharmaceuticals and life sciences industry

    11/20/13 | Pharmaceuticals & life science

    This publication highlights factors the industry should consider and provides guidance on the most pertinent accounting solutions under US GAAP. The solutions presented are meant to provide a framework for determining the appropriate accounting answer for general solutions.